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Abstract
Background: Plasma fatty acid (FA) composition reflects dietary intake and endogenous turnover and is associated with
health outcomes on a short and long term basis. The total plasma FA pool represents the composition of all FA containing
lipid fractions. We developed a simplified and affordable high-throughput method for the analysis of total plasma FA
composition, suitable for large studies.
Methodology/Principal Findings: The total lipid FA from 100 ml plasma is transferred in situ into methyl esters, avoiding
initial extraction and drying steps. The fatty acid methyl esters are extracted once and analyzed by gas chromatography. For
the new direct in situ transesterification method optimal, reaction parameters were determined. Intra-assay analysis (n = 8)
revealed coefficients of variation below 4% for FA contributing more than 1% to total FA.
Conclusions/Significance: The results show good agreement with FA concentrations obtained by a reference method. The
new direct in situ transesterification method is robust and simple. Sample preparation time and analysis costs are reduced
to a minimum. This method is an economically and ecologically superior alternative to conventional methods for assessing
plasma FA status in large studies.
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Introduction
Tissue availability of polyunsaturated fatty acids, which depends
on both diet and metabolic turnover, has a major impact on
human health [1–3]. An adequate supply is very important in
every stage of life, but particularly for the fetus and neonate to
enable optimal visual and cognitive development [4,5].
Analysis of fatty acid (FA) composition in different blood and
lipid fractions seems to be a valuable biomarker to assess the FA
status in humans [6–8]. Depending on the scientific question, the
FA composition can be determined in adipose tissue, erythrocytes,
plasma, platelets, whole blood, and other cells or tissues.
The most convenient way to asses FA composition is in whole
blood, because separation of plasma and lipid fractions is not required
and dried blood spots have been shown as suitable for analysis [9,10].
However, the procedure is not yet well established [9,11,12] and data
interpretation seems more difficult, because different influencing
factors have to be considered. A crucial influencing factor is the
hematocrit, which depends on gender [13] and age, e.g. hematocrit is
higher in neonates than adults and decreases during the first months
of life [14]. The hematocrit may be altered by factors such as
hypertension [13], pulmonary and cardiac diseases, and pregnancy
[15]. Variation of hematocrit may lead to misinterpretation of whole
blood FA data because the FA composition of plasma and red blood
cells, the main components of whole blood, differs significantly [6].
Analytical precision can be improved by analyzing the FA
composition in plasma glycerophospholipids, which contain high
percentages of e.g. docosahexaenoic acid and hence are a sensitive
biomarker for long chain polyunsaturated FA body status [6]. The
analysis of plasma glycerophospholipid FA composition can be
performed with a high-throughput methodology [16] in large
studies. In addition to this very sensitive method focusing on a
specific plasma lipid fraction, it could be revealing to analyze the
plasma total FA pool, which represents a mixture of all plasma
lipid fractions that contain FA moieties, in particular cholesteryl
esters, nonesterified FA, phospholipids, and triglycerides. The FA
composition is typical for each lipid class, as specific FA are
preferentially partitioned into different plasma lipid pools [17].
Thus, analysis of the total FA pool offers the opportunity to
determine overall changes in plasma FA status. However, to assess
total FA composition in large studies, methods have to be robust
and affordable.
Lepage and Roy [18] developed the first direct transesterifica-
tion method to assess total FA composition in plasma. Masood,
Stark and Salem [19] presented in 2005 a simplified version of the
original method of Lepage and Roy. In 2008 Masood and Salem
[20] published a modified version of this method, which enables a
half automated sample preparation.
We aimed to simplify the assessment of total FA composition in
plasma with as few sample preparation steps as possible to enable
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its application in large studies. Furthermore, we tried to confine
sample volume, consumable, reagent, and solvent requirements to
a minimum and perform all preparation steps in one vial. We
compared our method with a reference method and examined the
reliability and limitations of the new method.
Materials and Methods
Reagents and biological material
We used anonymous leftover plasma samples that were
originally obtained from patients of the Dr. von Hauner Children’s
Hospital for clinical diagnostics. Five anonymous patient samples
were pooled. This pooled sample was aliquoted, stored, and used
for analysis of intra-assay reproducibility and the influence of
different reaction conditions. Another five anonymous patient
samples were pooled to obtain the sample used for storability
analysis. For each of the sixteen samples used for comparison
analysis of the new with the reference method, five anonymous
patient samples were pooled. The ethical committee of the
University of Munich Medical Faculty approved this procedure
and approved that no informed consent was needed in this case.
Analytical-grade chloroform, hexane, methanol, and water were
purchased from Merck KGaA (Darmstadt, Germany) and
methanolic HCl (3 N) was obtained from Sigma-Aldrich (Tauf-
kirchen, Germany). Pentadecanoic acid, cholesteryl pentadecano-
ate, tripentadecanoin, and 1,2-dipentadecanoyl-sn-glycero-3-
phosphocholine (Sigma-Aldrich) were dissolved in methanol/
chloroform (35:15) and used as internal standard. To prevent
FA oxidation 2 g/l 2,6-di-tert-butyl-p-cresol (Sigma-Aldrich) was
added to the internal standard. The external standard (GLC-85),
containing 32 fatty acid methyl esters (FAME), was purchased
from Nu-Check Prep, Inc. (Elysian, MN, USA). A mixture of
sodium carbonate, sodium hydrogen carbonate and sodium sulfate
(1:2:2, Merck KGaA) was applied as buffer for neutralization after
acid catalyzed transesterification.
New direct in situ transesterification method
We developed a method for the analysis of total plasma FA
compositions requiring small plasma (100 ml), reagent (1.5 ml),
and solvent volumes (0.6 ml) and few sample preparation steps.
According to the newly developed method, 100 ml of plasma,
100 ml of internal standard and 1.5 ml methanolic HCl (3 N,
containing 2 g/l 2,6-di-tert-butyl-p-cresol) were combined in closed
glass tubes. The samples were shaken for 30 s and heated to 85uC
for 45 min. After cooling to room temperature, 0.5 ml hexane
(containing 2 g/l 2,6-di-tert-butyl-p-cresol) was added and the tubes
were shaken for 30 s. Phase separation occurred after approx.
1 min at room temperature. For storage and gas chromatographic
(GC) analysis an aliquot of the upper hexane phase was transferred
into 2 ml vials. A schematic diagram of the procedure is given in
Figure 1.
Reference method
We analyzed the total plasma FA composition according to a
reference method to compare the results with that obtained by the
new method. For this purpose, we used the standard procedure
established in our laboratory, which is based on Folch extraction.
In detail, 100 ml of internal standard was added to 250 ml plasma
and lipids were extracted by a modified Folch method [21] using
chloroform/methanol (2:1, v/v). The extract was washed two
times with NaCl solution (2% in water) and subsequently dried at
30uC under reduced pressure. For methyl ester synthesis the
extract was taken up in 400 ml chloroform/methanol and 1.5 ml
methanolic HCl (3 N) were added. The tubes were closed, shaken
for 30 s, and heated to 85uC for 45 min. Samples were neutralized
with carbonate buffer after cooling to room temperature. 1 ml
hexane was added for FAME extraction. After centrifugation at
9006g for 5 min the upper hexane phase was transferred into a
further glass tube and the extraction was repeated. The extracts
were combined, taken to dryness under nitrogen flow at room
temperature, and taken up in 50 ml hexane (containing 2 g/l 2,6-
di-tert-butyl-p-cresol) for GC analysis.
Chromatography
The individual FAME were quantified by GC with flame
ionization detection. GC analysis was performed on an Agilent
5890 series II GC (Agilent, Waldbronn, Germany) using a BPX 70
column (25 m60.22 mm, 25 mm film, SGE, Weiterstadt, Ger-
many). The temperature program started with an initial
temperature of 150uC, which was increased with 2.5uC/min to
180uC and 1.5uC/min to 200uC followed by an 1 min isothermal
period. Helium was used as carrier gas, starting with a column
head pressure of 0.9 bar, which was increased with 0.02 bar/min
to 1.2 bar, with 0.05 bar/min to 1.5 bar, and 0.1 bar/min to the
final pressure of 2.0 bar.
Data quantitation
Peak integration was performed using EZChrom Elite version
3.1.7. Individual FAME were identified using authentic standards
for comparisons. We used a FAME mixture (GLC-85) as external
standard, which was analyzed directly by GC and used to
Figure 1. Schematic diagram of the procedure according the direct in situ transesterification method to assess the total fatty acid
composition in a plasma sample (GC, gas chromatography).
doi:10.1371/journal.pone.0012045.g001
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determine the response of each FAME relative to pentadecanoic
acid methyl ester.
Method comparison and statistical analysis
Results were expressed as absolute plasma concentrations (mg/l)
and as percentage values (% wt/wt), and FA data were presented
as mean. Intra-assay reproducibility was obtained by analyzing 8
aliquots of a pooled plasma sample at an interval of 1 week.
Coefficients of variation (CV, %) were used to express analytical
precision. The statistical differences between both methods were
obtained by analyzing 16 different plasma samples (pooled) and
paired t-test was used for comparison between the mean values.
All statistical analyses were performed with SPSS for Windows,
Version 15.0.1 (SPSS Inc., Chicago, IL, USA).
Results
Intra-assay reproducibility obtained by the analysis of 8 aliquots
of one plasma sample at an interval of 1 week was determined for
both methods. Coefficients of variation (Table 1) for all FA
contributing more than 1% of total FA were below 4% with the
direct in situ transesterification method. Analysis of C22:0,
contributing 0.34% of total FA, showed the highest CV (8%).
Furthermore, we analyzed the FA concentrations of sixteen
different pooled plasma samples (Table S1). The measured total FA
concentrations for these samples were 2715.9 mg/l (range
1851.1 mg/l–5409.8 mg/l) with the reference method and
2913.2 mg/l (range 1936.0 mg/l–5865.0 mg/l) with the direct in situ
transesterification method. Absolute plasma concentrations (mg/l)
Table 1. Intra-assay (8 independent measurements of 1 sample) reproducibility of total lipid fatty acid (FA) concentrations (mg/l)
and compositions (% wt/wt) obtained by analysis according to the reference and the direct in situ transesterification method (CV,
coefficient of variation; PUFA, polyunsaturated fatty acid).
FA Reference method Direct in situ transesterification method
FA concentration FA composition FA concentration FA composition
Mean CV Mean CV Mean CV Mean CV
Saturated FA
C14:0 51.90 3.0 1.53 3.5 70.90 3.7 1.87 3.6
C16:0 901.81 2.6 26.54 1.2 975.65 1.7 25.76 0.7
C17:0 11.48 2.9 0.34 2.3 11.55 3.9 0.30 3.2
C18:0 276.75 5.9 8.14 4.2 278.15 1.5 7.34 0.7
C20:0 10.39 3.4 0.31 1.8 8.60 4.3 0.23 4.1
C22:0 21.54 2.9 0.63 2.2 16.15 7.9 0.43 8.0
C24:0 17.53 4.4 0.52 4.2 15.10 7.0 0.40 7.4
Monounsaturated FA
C14:1 3.99 7.9 0.12 8.7 6.45 4.0 0.17 3.7
C16:1n-7 93.56 1.4 2.75 1.3 107.40 3.1 2.84 2.9
C18:1n-7 65.49 2.1 1.93 0.9 69.40 3.2 1.83 2.9
C18:1n-9 839.26 2.1 24.70 0.9 914.55 1.3 24.14 0.3
C20:1n-9 7.31 3.5 0.22 3.1 7.10 5.8 0.19 5.7
C24:1n-9 31.16 3.5 0.92 3.1 31.35 5.7 0.83 5.4
n-9 PUFA
C20:3n-9 4.48 2.6 0.13 0.8 5.90 4.8 0.16 4.9
n-6 PUFA
C18:2n-6 719.04 1.8 21.16 0.7 836.60 1.4 22.09 0.3
C18:3n-6 14.91 6.0 0.44 7.0 18.00 2.4 0.48 1.4
C20:2n-6 6.01 4.4 0.18 5.0 6.40 5.8 0.17 5.2
C20:3n-6 47.86 2.4 1.41 1.5 58.50 1.7 1.54 1.1
C20:4n-6 172.53 2.3 5.08 1.7 219.50 1.1 5.79 1.0
C22:4n-6 6.78 4.7 0.20 5.2 8.50 7.0 0.22 7.0
C22:5n-6 4.74 9.5 0.14 10.1 6.50 7.2 0.17 7.8
n-3 PUFA
C18:3n-3 13.83 1.9 0.41 1.2 17.20 1.8 0.45 1.2
C20:5n-3 18.41 9.5 0.54 9.6 21.55 2.9 0.57 2.2
C22:5n-3 13.38 3.6 0.39 3.4 17.15 3.4 0.45 3.0
C22:6n-3 43.78 2.8 1.29 2.8 59.80 1.9 1.58 1.6
Total FA
3397.89 2.1 3787.95 1.3
doi:10.1371/journal.pone.0012045.t001
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were significantly higher for most of the analyzed FA with the direct
in situ transesterification method compared to the reference method.
There were no significant differences in the concentrations for the
saturated FA C17:0, C20:0, and C22:0, for the monounsaturated FA
C14:1n-5 and C20:1n-9, and for the polyunsaturated FA C20:2n-6,
C22:4n-6, C22:5n-6, C18:3n-3, and C20:5n-3. The concentration of
C18:3n-6 was higher obtained with the reference methods compared
to the direct in situ transesterification method. For all other FA,
particularly docosahexaenoic acid, absolute plasma concentrations
were higher with the direct in situ transesterification method than
with the reference method. However, both methods revealed very
similar percentage FA values (% wt/wt).
We assessed the effects of reaction conditions on the determined
FA in more detail (Table S2). Both, longer reaction times (90 min
instead of 45 min) as well as an increase of the reaction
temperature from 85uC to 100uC led to higher concentration
yields for C20:0, C22:0, C24:0, and C24:1n-9 (up to 40%). No
further increase in concentrations was obtained with prolonging
reaction times beyond 90 min. However, the effect on percentage
FA compositions is very small, because of the low abundance of
these four FA (,1% of total FA).
Storage of the GC ready derivatives for one month at220uC did
not lead to appreciable alterations of FA concentrations (Table 2).
Discussion
The new analysis method allows for rapid, precise, and
reproducible analysis of total plasma FA. Significantly higher
Table 2. Fatty acid (FA) values obtained with the new direct in situ transesterification method for a plasma sample analyzed by
gas chromatography directly after sample preparation, then stored for 1 month at 220uC and analyzed again (PUFA,
polyunsaturated fatty acid).
FA FA concentration (mg/l) FA composition (% wt/wt)
Start 4 weeks Difference Start 4 weeks Difference
mg/l % % wt/wt %
Saturated FA
C14:0 57.40 57.60 0.20 0.3 1.66 1.66 0.00 0.1
C16:0 896.20 899.20 3.00 0.3 25.86 25.88 0.02 0.1
C17:0 10.80 10.80 0.00 0.0 0.31 0.31 0.00 20.3
C18:0 258.40 263.40 5.00 1.9 7.46 7.58 0.13 1.7
C20:0 8.10 8.40 0.30 3.7 0.23 0.24 0.01 3.4
C22:0 14.80 15.60 0.80 5.4 0.43 0.45 0.02 5.1
C24:0 13.90 14.80 0.90 6.5 0.40 0.43 0.02 6.2
Monounsaturated FA
C14:1n-5 5.40 5.40 0.00 0.0 0.16 0.16 0.00 20.3
C16:1n-7 99.60 97.80 21.80 21.8 2.87 2.81 20.06 22.1
C18:1n-7 65.80 67.20 1.40 2.1 1.90 1.93 0.04 1.9
C18:1n-9 860.80 857.00 23.80 20.4 24.84 24.66 20.17 20.7
C20:1n-9 8.20 7.80 20.40 24.9 0.24 0.22 20.01 25.1
C24:1n-9 27.20 29.40 2.20 8.1 0.78 0.85 0.06 7.8
n-9 PUFA
C20:3n-9 5.00 5.20 0.20 4.0 0.14 0.15 0.01 3.7
n-6 PUFA
C18:2n-6 762.60 758.00 24.60 20.6 22.00 21.82 20.19 20.9
C18:3n-6 15.60 15.40 20.20 21.3 0.45 0.44 20.01 21.5
C20:2n-6 6.00 6.20 0.20 3.3 0.17 0.18 0.01 3.1
C20:3n-6 52.60 52.60 0.00 0.0 1.52 1.51 0.00 20.3
C20:4n-6 187.80 192.00 4.20 2.2 5.42 5.53 0.11 2.0
C22:4n-6 7.60 7.40 20.20 22.6 0.22 0.21 20.01 22.9
C22:5n-6 4.50 4.80 0.30 6.7 0.13 0.14 0.01 6.4
n-3 PUFA
C18:3n-3 15.00 14.60 20.40 22.7 0.43 0.42 20.01 22.9
C20:5n-3 16.60 17.20 0.60 3.6 0.48 0.50 0.02 3.4
C22:5n-3 16.00 15.60 20.40 22.5 0.46 0.45 20.01 22.7
C22:6n-3 50.00 51.20 1.20 2.4 1.44 1.47 0.03 2.1
Total FA
3465.90 3474.60 8.70 0.3
doi:10.1371/journal.pone.0012045.t002
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absolute plasma concentrations for most of the analyzed FA were
obtained by direct in situ transesterification compared to our
reference method, presumably because losses due to non-
quantitative extraction are avoided by the direct in situ
transesterification method as previously noted by other authors
[18,22]. Of importance, the addition of an internal standard
dissolved in an organic solvent to the plasma sample obviously is
not fully adequate for the extraction of lipoprotein bound lipids.
Absolute plasma FA concentration of C20:0 obtained by direct
in situ transesterification for 45 min at 85uC was lower than
concentrations found with the reference method. Longer reaction
times and/or higher temperatures enabled more complete direct
in situ transesterification of C20:0, C22:0, C24:0, and C24:1n-9.
These FA are mainly found in the phospholipid fraction of human
plasma [23]. The concentrations of these FA in glyceropho-
spholipids are below the quantification level, whereas they show a
high abundance in sphingomyelin [23]. Masood et al. [19]
obtained a decline of 40% of certain FA (C20:0, C22:0, C24:0 and
C24:1n-9) with transesterification at 75uC for 60 min–90 min with
their open-tube method compared to the direct transesterification
method of Lepage and Roy [18]. They considered that more
extreme conditions such as higher temperatures and longer
heating times were required for complete transesterification of
sphingomyelin FA, because of their less reactive amide bonds.
Quantitative transesterification of these FA would require at least
duplication of reaction time. However, the benefit of exact
determination of the concentrations of C20:0, C22:0, and C24:0
seems small for most clinical and research applications, which
must be weighed against the loss of productivity and the increasing
risk of FA degradation or isomerization during derivatization [24–
26]. Moreover, for most applications the percentage FA
compositions are of interest, which are constant at the different
reaction conditions, because the amounts of C20:0, C22:0, and
C24:0 are too small to alter the entire composition.
Different lipoproteins contain distinct amounts of cholesteryl
esters, phospholipids, and triglycerides, which have an individual
FA composition. Therefore, the FA composition obtained by
direct in situ transesterification in plasma reflects the total plasma
FA composition given by the composition of different lipoproteins
and the non-esterified FA.
In conclusion, the newly developed direct in situ transesterifi-
cation method presented here, enables analysis of total plasma FA
concentrations and percentage contributions from only 100 ml of
plasma. The method is robust and simple, because lipid extraction
and washing steps as well as neutralization, centrifugation and
drying steps are avoided and only one FAME extraction step is
required. Sample preparation can be performed in one vial,
preparation time is reduced to a minimum, and only small
volumes of reagents and solvents are necessary. Thus, the method
is economically and ecologically superior to conventional methods,
and it is well suitable for the application in large clinical trials and
epidemiological studies.
Supporting Information
Table S1 Differences between the reference and the direct in
situ transesterification method for total lipid fatty acid concentra-
tions (mean, mg/l) and compositions (mean, % wt/wt) obtained by
the analysis of 16 different plasma samples (pooled).
Found at: doi:10.1371/journal.pone.0012045.s001 (0.10 MB
DOC)
Table S2 Influence of different reaction conditions on the
determined fatty acid (FA) concentrations (mg/l) and compositions
(%) (PUFA, polyunsaturated fatty acid).
Found at: doi:10.1371/journal.pone.0012045.s002 (0.10 MB
DOC)
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